Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 5, 2006 - Issue 6
Submit an article Journal homepage
767
Views
97
CrossRef citations to date
0
Altmetric
Review

Anthracycline cardiotoxicity

Robin L Jones Royal Marsden Hospital, Department of Medicine, Fulham Road, London, SW3 6JJ, UK. [email protected]
,
Charles Swanton Royal Marsden Hospital, Department of Medicine, Fulham Road, London, SW3 6JJ, UK. [email protected]; CR-UK London Research Institute, Signal Transduction Laboratory, 44 Lincoln’s Inn Fields, London, WC2A 3PX, UK
&
Michael S Ewer The University of Texas MD Anderson Cancer Center, Department of Cardiology, Houston, TX 77030, USA
Pages 791-809 | Published online: 18 Oct 2006

Citations (97)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Antonia Digklia, Ana Dolcan, Monika A Kucharczyk, Robin L Jones & Andrea Napolitano. (2023) Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma. Cancer Management and Research 15, pages 537-545.
Read now
Antonis A. Manolis, Theodora A. Manolis, Dimitri P. Mikhailidis & Antonis S. Manolis. (2018) Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies – part 1. Expert Opinion on Drug Safety 17:9, pages 875-892.
Read now
Amy A Kirkham, Sean A Virani & Kristin L Campbell. (2015) The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review. International Journal of Women's Health 7, pages 127-140.
Read now
Syed Wamique Yusuf, Nasreen A Ilias-Khan & Jean-Bernard Durand. (2011) Chemotherapy-induced cardiomyopathy. Expert Review of Cardiovascular Therapy 9:2, pages 231-243.
Read now
Robin L Jones. (2008) Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity. Expert Review of Cardiovascular Therapy 6:10, pages 1311-1317.
Read now
Nenad Sarapa & Margaret R Britto. (2008) Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents. Expert Opinion on Drug Safety 7:3, pages 305-318.
Read now
Alessandro M Minisini, Claudia Andreetta, Gianpiero Fasola & Fabio Puglisi. (2008) Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer. Expert Review of Anticancer Therapy 8:3, pages 331-342.
Read now
Ashley Simmons, James L. Vacek & David Meyers. (2008) Anthracycline-Induced Cardiomyopathy. Postgraduate Medicine 120:4, pages 67-72.
Read now
Janos Nadas & Duxin Sun. (2006) Anthracyclines as effective anticancer drugs. Expert Opinion on Drug Discovery 1:6, pages 549-568.
Read now

Articles from other publishers (88)

Marie C. Fortin, Andrew S. LaCroix, Tom N. Grammatopoulos, Lei Tan, Qi Wang & Dino Manca. (2023) Lower cardiotoxicity of CPX-351 relative to daunorubicin plus cytarabine free-drug combination in hiPSC-derived cardiomyocytes in vitro. Scientific Reports 13:1.
Crossref
Tengfei Wang, Shuxiang Shi, Yuanyuan Shi, Peipei Jiang, Ganlu Hu, Qinying Ye, Zhan Shi, Kexin Yu, Chenguang Wang, Guoping Fan, Suwen Zhao, Hanhui Ma, Alex C. Y. Chang, Zhi Li, Qian Bian & Chao-Po Lin. (2023) Chemical-induced phase transition and global conformational reorganization of chromatin. Nature Communications 14:1.
Crossref
James A. Roberts, Richard D. Rainbow & Parveen Sharma. (2023) Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling. International Journal of Molecular Sciences 24:7, pages 6723.
Crossref
Jizong Jiang, Lingyan Ni, Xinxin Zhang, Priyanka Gokulnath, Gururaja Vulugundam, Guoping Li, Hongyun Wang & Junjie Xiao. (2023) Moderate‐Intensity Exercise Maintains Redox Homeostasis for Cardiovascular Health. Advanced Biology 7:4.
Crossref
Isobel C Jones & Crispin R Dass. (2022) Doxorubicin-induced cardiotoxicity: causative factors and possible interventions. Journal of Pharmacy and Pharmacology 74:12, pages 1677-1688.
Crossref
Marcus Vinicius Machado, Ronan Chapuis & Aline Bomfim Vieira. (2022) Can Exercise Training Prevent Doxorubicin-induced Cardiomyopathy?. International Journal of Cardiovascular Sciences 35:6, pages 727-729.
Crossref
Maedeh Bagheri Moghaddam, Majid Maleki, Maziar Oveisee, Mahrokh Bagheri Moghaddam, Maedeh Arabian & Mahshid Malakootian. (2022) Circular RNAs: New Players in Cardiomyopathy. Genes 13:9, pages 1537.
Crossref
Maryam Armandeh, Behnaz Bameri, Mahedeh Samadi, Shima Heidari, Roham Foroumadi & Mohammad Abdollahi. (2022) A Systematic Review of Nonclinical Studies on the Effect of Curcumin in Chemotherapy- induced Cardiotoxicity. Current Pharmaceutical Design 28:22, pages 1843-1853.
Crossref
Sabina Y. van der Zanden, Xiaohang Qiao & Jacques Neefjes. (2020) New insights into the activities and toxicities of the old anticancer drug doxorubicin. The FEBS Journal 288:21, pages 6095-6111.
Crossref
Yu. A. Vasyuk, G. E. Gendlin, E. I. Emelina, E. Yu. Shupenina, M. F. Ballyuzek, I. V. Barinova, M. V. Vitsenya, I. L. Davydkin, D. P. Dundua, D. V. Duplyakov, D. A. Zateishchikov, I. A. Zolotovskaya, A. O. Konradi, Yu. M. Lopatin, O. M. Moiseeva, S. V. Nedogoda, A. O. Nedoshivin, I. G. Nikitin, M. G. Poltavskaya, V. I. Potievskaya, A. N. Repin, А. N. Sumin, L. A. Zotova, G. S. Tumyan, E. V. Shlyakhto, I. E. Khatkov, S. S. Yakushin & Yu. N. Belenkov. (2021) Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy. Russian Journal of Cardiology 26:9, pages 4703.
Crossref
Tigran Makunts, Ila M. Saunders, Isaac V. Cohen, Mengxing Li, Talar Moumedjian, Masara A. Issa, Keith Burkhart, Peter Lee, Sandip Pravin Patel & Ruben Abagyan. (2021) Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data. Scientific Reports 11:1.
Crossref
Robin L. Jones, Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine, Javier Martín-Broto, Patrick M. Peterson, Jennifer Wright & William D. Tap. (2021) Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial. Clinical Cancer Research 27:14, pages 3861-3866.
Crossref
Yanping Zhang, Le Ni, Bowen Lin, Lingjie Hu, Zheyi Lin, Jian Yang, Jinyu Wang, Honghui Ma, Yi Liu, Jian Yang, Jianghua Lin, Liang Xu, Liqun Wu & Dan Shi. (2021) SNX17 protects the heart from doxorubicin-induced cardiotoxicity by modulating LMOD2 degradation. Pharmacological Research 169, pages 105642.
Crossref
Kyle Farina, Matko Kalac & Sara Kim. (2020) Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma. Journal of Oncology Pharmacy Practice 27:4, pages 1011-1015.
Crossref
Toshio Kinoshita, Hitomi Yuzawa, Kazuhiko Natori, Ryo Wada, Shintaro Yao, Kensuke Yano, Katsuya Akitsu, Hideki Koike, Masaya Shinohara, Tadashi Fujino, Hideaki Shimada & Takanori Ikeda. (2021) Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity. Journal of Cardiology 77:4, pages 388-394.
Crossref
Dennis P. A. Wander, Sabina Y. van der Zanden, Gijsbert A. van der Marel, Herman S. Overkleeft, Jacques Neefjes & Jeroen D. C. Codée. (2020) Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents. Journal of Medicinal Chemistry 63:21, pages 12814-12829.
Crossref
Thomas Christensen, Tobias Berg, Lise Birk Nielsen, Michael Andersson, Maj-Britt Jensen & Ann Knoop. (2020) Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients. The Breast 51, pages 34-39.
Crossref
Carmine RoccaTeresa PasquaMaria Carmela CerraTommaso Angelone. (2020) Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation. Antioxidants & Redox Signaling 32:15, pages 1081-1097.
Crossref
Annabel Alig, Michael von Bergwelt & Clemens Gießen-Jung. (2019) Notfälle unter medikamentöser TumortherapieEmergencies under drug anti-cancer treatment. Der Onkologe 26:2, pages 120-128.
Crossref
Marijan PejicMonica ShifmanTrevor RoseDaniel Jeong. (2019) Chronic Anthracycline-related Myocarditis Presenting as Diffuse Myocardial Calcification. Journal of Clinical Imaging Science 9, pages 47.
Crossref
Maria Theodosiou, Nikos Boukos, Elias Sakellis, Michael Zachariadis & Eleni K. Efthimiadou. (2019) Gold nanoparticle decorated pH-sensitive polymeric nanocontainers as a potential theranostic agent. Colloids and Surfaces B: Biointerfaces 183, pages 110420.
Crossref
Lei Xu, Zhicheng Zhang, Yawen Ding, Li Wang, Yali Cheng, Lingtong Meng, Jinhui Wu, Ahu Yuan, Yiqiao Hu & Yishen Zhu. (2019) Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species. Biomaterials Science 7:11, pages 4782-4789.
Crossref
Jing Xu, Dandan Liu, Shengxiang Xiao, Xinxin Meng, Di Zhao, Xin Jiang, Xue Jiang, Lu Cai & Hongyu Jiang. (2019) Low-Dose Radiation Prevents Chemotherapy-Induced Cardiotoxicity. Current Stem Cell Reports 5:2, pages 82-91.
Crossref
Ciro Santoro, Roberta Esposito, Covadonga Fernández-Golfín, Maurizio Galderisi & Jose Luis Zamorano Gomez. 2019. Cardiovascular Complications in Cancer Therapy. Cardiovascular Complications in Cancer Therapy 165 172 .
Alexander Bourdon, Scott A. Grandy & Melanie R. Keats. (2018) Aerobic exercise and cardiopulmonary fitness in childhood cancer survivors treated with a cardiotoxic agent: a meta-analysis. Supportive Care in Cancer 26:7, pages 2113-2123.
Crossref
Puey Ling Chia, K Chiang, R Snyder & A Dowling. (2017) The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity. Journal of Oncology Pharmacy Practice 24:4, pages 264-271.
Crossref
Lidia Villanova, Silvia Careccia, Ruggero De Maria & Micol Fiori. (2018) Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members. International Journal of Molecular Sciences 19:4, pages 958.
Crossref
Francois Dionne, Folefac Aminkeng, Amit P. Bhavsar, Gabriella Groeneweg, Anne Smith, Henk Visscher, Shahrad Rod Rassekh, Colin Ross & Bruce Carleton. (2018) An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines. Pediatric Blood & Cancer 65:3, pages e26887.
Crossref
Timothy M. Markman & Maurie Markman. (2018) Cardio-Oncology: mechanisms of cardiovascular toxicity. F1000Research 7, pages 113.
Crossref
I. Brana, E. Zamora, G. Oristrell & J. Tabernero. 2018. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 367 406 .
Jie-Ning Zhu, Yong-Heng Fu, Zhi-qin Hu, Wen-Yu Li, Chun-Mei Tang, Hong-Wen Fei, Hui Yang, Qiu-xiong Lin, De-Ming Gou, Shu-Lin Wu & Zhi-Xin Shan. (2017) Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity. Scientific Reports 7:1.
Crossref
Andrea Morandi & Stefano Indraccolo. (2017) Linking metabolic reprogramming to therapy resistance in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 1-6.
Crossref
Agnes Maillet, Kim Peng Tan & Liam R. Brunham. (2017) Use of Human Pluripotent Stem Cell Derived‐Cardiomyocytes to Study Drug‐Induced Cardiotoxicity. Current Protocols in Toxicology 73:1.
Crossref
Angela Esposito, Carmen Criscitiello, Douglas B. Sawyer & Giuseppe Curigliano. 2017. Cardio-Oncology. Cardio-Oncology 241 252 .
Li-juan Shen, Shu Lu, Yong-hua Zhou, Lan Li, Qing-min Xing & Yong-liang Xu. (2016) Developing a rat model of dilated cardiomyopathy with improved survival提高扩张型心肌病动物模型的生存率. Journal of Zhejiang University-SCIENCE B 17:12, pages 975-983.
Crossref
Pei-Chen Huang, Wei-Wen Kuo, Chia-Yao Shen, Yu-Feng Chen, Yueh-Min Lin, Tsung-Jung Ho, V. Padma, Jeng-Fan Lo, Chih-Yang Huang & Chih-Yang Huang. (2016) Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway. International Journal of Molecular Sciences 17:9, pages 1588.
Crossref
Ibrahim Fanous & Patrick Dillon. (2016) Cancer treatment-related cardiac toxicity: prevention, assessment and management. Medical Oncology 33:8.
Crossref
S Saranya & V Vijaya. 2016. Holistic Healthcare. Holistic Healthcare 209 236 .
Yasmin Hamirani, Ibrahim Fanous, Christopher M. Kramer, Andrew Wong, Michael Salerno & Patrick Dillon. (2016) Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study. Medical Oncology 33:7.
Crossref
Tao Yue, Ki Ho Park, Benjamin E. Reese, Hua Zhu, Seth Lyon, Jianjie Ma, Peter J. Mohler & Mingjun Zhang. (2016) Quantifying Drug-Induced Nanomechanics and Mechanical Effects to Single Cardiomyocytes for Optimal Drug Administration To Minimize Cardiotoxicity. Langmuir 32:7, pages 1909-1919.
Crossref
Andrea Mantuano, Regina Cely Barroso, Liebert Parreiras Nogueira, Marcos Vinicius Colaço, Carla Lemos Mota, Arissa Pickler, Delson Braz, Camila Salata, Samara Ferreira-Machado, Carlos Eduardo de Almeida & Alessandra Gianoncelli. (2016) Alterations in Low-Z Elements Distribution in Heart Tissue after Treatments to Breast Cancer Using LEXRF Technique. American Journal of Analytical Chemistry 07:11, pages 754-771.
Crossref
Jin Sin Koh, Chin-ok Yi, Rok Won Heo, Jong-Wha Ahn, Jeong Rang Park, Jung Eun Lee, Jung-Hwan Kim, Jin-Yong Hwang & Gu Seob Roh. (2015) Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice. Free Radical Biology and Medicine 89, pages 54-61.
Crossref
Jean-Philippe Spano, David Azria & Anthony Gonçalves. (2015) Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy. Critical Reviews in Oncology/Hematology 94:3, pages 270-278.
Crossref
Meryl J. AlappattuRogelio A. CoronadoDerek LeeBarbara BourSteven Z. George. (2015) Clinical Characteristics of Patients With Cancer Referred for Outpatient Physical Therapy. Physical Therapy 95:4, pages 526-538.
Crossref
Angela Esposito, Lucia Gelao, Carmen Criscitiello & Giuseppe Curigliano. 2015. Heart and Toxins. Heart and Toxins 341 361 .
Jan M. Horacek, Martina Vasatova, Radek Pudil, Milos Tichy, Pavel Zak, Martin Jakl, Ladislav Jebavy & Jaroslav Maly. (2014) Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status. Biomedical Papers 158:4, pages 511-517.
Crossref
Timothy M. Markman & Maurie Markman. (2014) Cardiotoxicity of Antineoplastic Agents: What Is the Present and Future Role for Imaging?. Current Oncology Reports 16:8.
Crossref
Seung Jeong, Hyoung Kim, In-Sung Song, Seon Lee, Kyung Ko, Byoung Rhee, Nari Kim, Natalia Mishchenko, Sergey Fedoryev, Valentin Stonik & Jin Han. (2014) Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic Drugs. Marine Drugs 12:5, pages 2922-2936.
Crossref
Olga Len?ov?-Popelov?Eduard Jirkovsk?Yvona Mazurov?Juraj Len?o, Michaela Adamcov?Tom?? ?im?nek, Vladim?r Ger?l & Martin ?t?rba. (2014) Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up. PLoS ONE 9:5, pages e96055.
Crossref
Yoshihiko Ichikawa, Mohsen Ghanefar, Marina Bayeva, Rongxue Wu, Arineh Khechaduri, Sathyamangla V. Naga Prasad, R. Kannan Mutharasan, Tejaswitha Jairaj Naik & Hossein Ardehali. (2014) Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. Journal of Clinical Investigation 124:2, pages 617-630.
Crossref
S. Ederhy, A. Hollebecque, N. Haddour, C. Massard, G. Fleury, C. Ferte, S. Adavane, B. Besse, F. Boccara, J.-C. Soria & A. Cohen. (2014) Prise en charge des complications cardiovasculaires des traitements en oncologie thoracique. Revue des Maladies Respiratoires 31:2, pages 173-180.
Crossref
Zhanna Livshits, Rama B. Rao & Silas W. Smith. (2014) An Approach to Chemotherapy-Associated Toxicity. Emergency Medicine Clinics of North America 32:1, pages 167-203.
Crossref
Maria Florescu, Lucia Stefania Magda, Oana Aurelia Enescu, Dan Jinga & Dragos Vinereanu. (2014) Early Detection of Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer. Journal of the American Society of Echocardiography 27:1, pages 83-92.
Crossref
Wojciech Jurczak, Sebastian Szmit, Marcin Soboci?ski, Maciej Machaczka, Joanna Drozd-Soko?owska, Monika Joks, Justyna Dzietczenia, Tomasz Wr?bel, Beata Kumiega, Jan Maciej Zaucha, Wanda Knopi?ska-Pos?uszny, Wojciech Spycha?owicz, Anna Prochwicz, Anna Drohomirecka & Aleksander B. Skotnicki. (2013) Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen ? A national multicenter study. International Journal of Cardiology 168:6, pages 5212-5217.
Crossref
Brent A. McLean, Pavel Zhabyeyev, Edith Pituskin, Ian Paterson, Mark J. Haykowsky & Gavin Y. Oudit. (2013) PI3K Inhibitors as Novel Cancer Therapies: Implications for Cardiovascular Medicine. Journal of Cardiac Failure 19:4, pages 268-282.
Crossref
Martin ŠtěrbaOlga PopelováAnna VávrováEduard JirkovskýPetra KovaříkováVladimír GeršlTomáš Šimůnek. (2013) Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection. Antioxidants & Redox Signaling 18:8, pages 899-929.
Crossref
Irene Braña, Esther Zamora & Josep Tabernero. 2013. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 483 530 .
S. Calvin Thigpen & Stephen A. Geraci. (2012) Prediction of Anthracycline-Induced Left Ventricular Dysfunction by Cardiac Troponins. Southern Medical Journal 105:12, pages 659-664.
Crossref
Kathryn J Ruddy & Ann H Partridge. (2012) Treatment of breast cancer in young women. Clinical Practice 9:2, pages 171-180.
Crossref
Jan M. Horáček. (2011) BIOMARKERS OF CARDIAC INJURY IN DETECTION OF CARDIOTOXICITY INDUCED BY CHEMOTHERAPEUTIC AGENTS. Military Medical Science Letters 80:3, pages 103-117.
Crossref
Joachim Yahalom & Carol S. Portlock. (2011) Long-Term Cardiac and Pulmonary Complications of Cancer Therapy. Heart Failure Clinics 7:3, pages 403-411.
Crossref
Dimo Dietrich, Manuel Krispin, J?rn Dietrich, Anne Fassbender, J?rn Lewin, Nadia Harbeck, Manfred Schmitt, Serenella Eppenberger-Castori, Vincent Vuaroqueaux, Fr?d?rique Spyratos, John A Foekens, Ralf Lesche & John WM Martens. (2010) CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients. BMC Cancer 10:1.
Crossref
S-E Al-Batran, M Güntner, C Pauligk, M Scholz, R Chen, B Beiss, S Stopatschinskaja, W Lerbs, N Harbeck & E Jäger. (2010) Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials. British Journal of Cancer 103:10, pages 1518-1523.
Crossref
I. Brana & J. Tabernero. (2010) Cardiotoxicity. Annals of Oncology 21, pages vii173-vii179.
Crossref
Christian Schindlbeck, D. Mayr, C. Olivier, B. Rack, V. Engelstaedter, J. Jueckstock, C. Jenderek, U. Andergassen, U. Jeschke & K. Friese. (2010) Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer. Journal of Cancer Research and Clinical Oncology 136:7, pages 1029-1037.
Crossref
Melissa Y. Carpentier, Tammy Weitzmann, Ziv Amir, Grace E. Dean & Ian N. Olver. 2011. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship 407 418 .
O Popelová, M Štěrba, P Hašková, T Šimůnek, M Hroch, I Gunčová, P Nachtigal, M Adamcová, V Geršl & Y Mazurová. (2009) Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death. British Journal of Cancer 101:5, pages 792-802.
Crossref
M. Jakl, J.M. Horacek, L. Jebavy & R. Pudil. (2009) Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia. Leukemia Research 33:8, pages e109-e110.
Crossref
P.J. Barrett-Lee, J.M. Dixon, C. Farrell, A. Jones, R. Leonard, N. Murray, C. Palmieri, C.J. Plummer, A. Stanley & M.W. Verrill. (2009) Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Annals of Oncology 20:5, pages 816-827.
Crossref
Alessandra Gennari, Michele De Tursi, Consiglia Carella, Enrico Ricevuto, Cinzia Orlandini, Antonio Frassoldati, Pierfranco Conte, Paolo Bruzzi & Stefano Iacobelli. (2008) Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer. Breast Cancer Research and Treatment 115:1, pages 131-136.
Crossref
Elke Martin, Annemette Vinding Thougaard, Morten Grauslund, Peter B. Jensen, Fredrik Bjorkling, Brian B. Hasinoff, Jette Tj?rnelund, Maxwell Sehested & Lars H. Jensen. (2009) Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy. Toxicology 255:1-2, pages 72-79.
Crossref
Tomáš Šimůnek, Martin Štěrba, Olga Popelová, Michaela Adamcová, Radomír Hrdina & Vladimír Geršl. (2009) Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacological Reports 61:1, pages 154-171.
Crossref
Joshua C. Canzoneri & Adegboyega K. Oyelere. (2008) Interaction of anthracyclines with iron responsive element mRNAs. Nucleic Acids Research 36:21, pages 6825-6834.
Crossref
Daryl C. Drummond, Charles O. Noble, Mark E. Hayes, John W. Park & Dmitri B. Kirpotin. (2008) Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. Journal of Pharmaceutical Sciences 97:11, pages 4696-4740.
Crossref
T Šimůnek, M Štěrba, O Popelová, H Kaiserová, M Adamcová, M Hroch, P Hašková, P Poňka & V Geršl. (2008) Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. British Journal of Pharmacology 155:1, pages 138-148.
Crossref
Xiuzhen Han, Jihong Pan, Dongmei Ren, Yanna Cheng, Peihong Fan & Hongxiang Lou. (2008) Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food and Chemical Toxicology 46:9, pages 3140-3146.
Crossref
Olga Popelová, Martin Štěrba, Tomáš Šimůnek, Yvona Mazurová, Ivana Gunčová, Miloš Hroch, Michaela Adamcová & Vladimír Geršl. (2008) Deferiprone Does Not Protect against Chronic Anthracycline Cardiotoxicity in Vivo. Journal of Pharmacology and Experimental Therapeutics 326:1, pages 259-269.
Crossref
Margarete Schön, B. Gregor Wienrich, Susanne Kneitz, Helga Sennefelder, Katharina Amschler, Verena Vöhringer, Olaf Weber, Thorsten Stiewe, Karl Ziegelbauer & Michael P. Schön. (2008) KINK-1, a Novel Small-Molecule Inhibitor of IKKβ, and the Susceptibility of Melanoma Cells to Antitumoral Treatment. JNCI: Journal of the National Cancer Institute 100:12, pages 862-875.
Crossref
Joachim Yahalom & Carol S. Portlock. (2008) Long-Term Cardiac and Pulmonary Complications of Cancer Therapy. Hematology/Oncology Clinics of North America 22:2, pages 305-318.
Crossref
Syed Wamique Yusuf, Peter Razeghi & Edward T.H. Yeh. (2008) The Diagnosis and Management of Cardiovascular Disease in Cancer Patients. Current Problems in Cardiology 33:4, pages 163-196.
Crossref
Luigi Rigacci, Silvia Mappa, Luca Nassi, Renato Alterini, Valentina Carrai, Franco Bernardi & Alberto Bosi. (2007) Liposome‐encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre‐treated with anthracyclines. Hematological Oncology 25:4, pages 198-203.
Crossref
Edurne Arriola, Socorro Maria Rodriguez-Pinilla, Maryou B. K. Lambros, Robin L. Jones, Michelle James, Kay Savage, Ian E. Smith, Mitch Dowsett & Jorge S. Reis-Filho. (2007) Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Research and Treatment 106:2, pages 181-189.
Crossref
Helena Kaiserová, Tomáš Šimůnek, Wim J.F. van der Vijgh, Aalt Bast & Eva Kvasničková. (2007) Flavonoids as protectors against doxorubicin cardiotoxicity: Role of iron chelation, antioxidant activity and inhibition of carbonyl reductase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1772:9, pages 1065-1074.
Crossref
Dan Radulescu, Sorin Pripon, Andreea Parv, Caius Duncea, Tudor E. Ciuleanu & Letitia I. Radulescu. (2007) Altered Left Ventricular Diastolic Performance in Oncologic Patients Treated With Epirubicin. Congestive Heart Failure 13:4, pages 215-220.
Crossref
Michaela Adamcová, Tomáš Šimůnek, Helena Kaiserová, Olga Popelová, Martin Štěrba, Anna Potáčová, Jaroslava Vávrová, Jana Maláková & Vladimír Geršl. (2007) In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. Toxicology 237:1-3, pages 218-228.
Crossref
Michael S. Ewer & Joyce A. O'Shaughnessy. (2007) Cardiac Toxicity of Trastuzumab-Related Regimens in HER2-Overexpressing Breast Cancer. Clinical Breast Cancer 7:8, pages 22-29.
Crossref
Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Yvona Mazurová, Anna Potáčová, Michaela Adamcová, Ivana Gunčová, Helena Kaiserová, Vladimír Palička, Přemysl Poňka & Vladimír Geršl. (2007) Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH). Toxicology 235:3, pages 150-166.
Crossref
S. Zierhut & A. Reichle. (2007) Der Leukämiepatient auf der IntensivstationThe patient with leukemia in the intensive care unit. Intensivmedizin und Notfallmedizin 44:5, pages 286-302.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.